Tiffany Farchione, MD, has contributed to the field of psychiatry with a focus on neurology and women's health. Her publications address topics including the reproductive safety of psychiatric medications in relation to FDA pregnancy and lactation labeling, as well as the FDA's perspective on the antipsychotic drug pimavanserin. She has collaborated with co-authors such as Adele C. Viguera and Aisar Atrakchi.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
